ATLANTA — A community service board wants to build a detox center for youths in the Fort Oglethorpe area. An Athens nonprofit has proposed buying two vans so it can get the vulnerable women it serves to their addiction treatment appointments. And Emory University aims to prevent burnout among police officers and other first responders on the frontlines of the deadly opioid overdose crisis.
They are among 240 organizations across the state that have submitted 308 applications seeking a total of $248.3 million in grants from Georgia’s Opioid Crisis Abatement Trust, according to records obtained by The Atlanta Journal-Constitution.
Regional and state officials plan to approve only a fraction of that — about $50 million — by this fall, though another application round is expected to begin early next year.
“We have a lot of opportunities to really put in place some innovative ideas and to be very selective about how this money is distributed,” said Kevin Tanner, who leads the trust and serves as the commissioner of Georgia’s Department of Behavioral Health & Developmental Disabilities.
Applicants rejected this year will have plenty of chances to try again. Over the next 18 years, about $479 million is expected to flow into Georgia’s trust. It will come from a $26 billion multistate court settlement reached with companies that made or distributed prescription painkillers linked to the opioid epidemic: AmerisourceBergen, now called Cencora; Cardinal Health; McKesson; and Janssen, now known as Johnson & Johnson Innovative Medicine.
